These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 29908442)

  • 21. New benzomorphan derivatives of MPCB as MOP and KOP receptor ligands.
    Pasquinucci L; Iadanza M; Marrazzo A; Prezzavento O; Ronsisvalle S; Scoto GM; Parenti C; De Luca L; Ronsisvalle G
    Pharmazie; 2007 Nov; 62(11):813-24. PubMed ID: 18065096
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 5-allyl-9-oxobenzomorphans. 3. Potent narcotic antagonists and analgesics-antagonists in the series of substituted 2',9beta-dihydroxy-6,7-benzomorphans.
    Saucier M; Daris JP; Lambert Y; Monkovié ; pircio AW
    J Med Chem; 1977 May; 20(5):676-82. PubMed ID: 16134
    [TBL] [Abstract][Full Text] [Related]  

  • 23. (+)-cis-N-ethyleneamino-N-normetazocine derivatives. Novel and selective sigma ligands with antagonist properties.
    Ronsisvalle G; Marrazzo A; Prezzavento O; Pasquinucci L; Vittorio F; Pittalà V; Pappalardo MS; Cacciaguerra S; Spampinato S
    J Med Chem; 1998 May; 41(10):1574-80. PubMed ID: 9572883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stereoselective synthesis and receptor binding of conformationally restricted and flexible 2,4-disubstituted 1,3-dioxanes derived from benzomorphans.
    Wünsch B; Bauschke G; Diekmann H; Höfner G
    Arch Pharm (Weinheim); 1999 Dec; 332(12):413-21. PubMed ID: 10634091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and pharmacology of 2,9alpha-dimethyl-2'-hydroxy-6,7-benzomorphan.
    Inoue H; May EL
    J Med Chem; 1976 Feb; 19(2):259-62. PubMed ID: 814236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An LP1 analogue, selective MOR agonist with a peculiar pharmacological profile, used to scrutiny the ligand binding domain.
    Ronsisvalle S; Aricò G; Panarello F; Spadaro A; Pasquinucci L; Pappalardo MS; Parenti C; Ronsisvalle N
    Bioorg Med Chem; 2016 Nov; 24(21):5280-5290. PubMed ID: 27624520
    [TBL] [Abstract][Full Text] [Related]  

  • 27. N-(2-Cyanoethyl) derivatives of meperidine, ketobemidone, and a potent 6,7-benzomorphan.
    Uwaydah IM; Waddle MK; Rogers ME
    J Med Chem; 1979 Jul; 22(7):889-90. PubMed ID: 109618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The σ1 receptor engages the redox-regulated HINT1 protein to bring opioid analgesia under NMDA receptor negative control.
    Rodríguez-Muñoz M; Sánchez-Blázquez P; Herrero-Labrador R; Martínez-Murillo R; Merlos M; Vela JM; Garzón J
    Antioxid Redox Signal; 2015 Apr; 22(10):799-818. PubMed ID: 25557043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BIII 277 CL is a potent and specific ion-channel blocker of the NMDA receptor-channel complex.
    Carter AJ; Bechtel WD; Grauert M; Harrison P; Merz H; Stransky W
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1382-9. PubMed ID: 8531106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analgesics and narcotic antagonists in the benzomorphan and 8-oxamorphinan series. 5.
    Lambert Y; Daris JP; Monković I; Pircio AW
    J Med Chem; 1978 May; 21(5):423-7. PubMed ID: 660584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The influence of esters and carboxylic acids as the N-substituent of opioids. Part 1: Benzomorphans.
    Metcalf MD; Aceto MD; Harris LS; Woods JH; Traynor JR; Coop A; May EL
    Bioorg Med Chem; 2008 Jan; 16(2):869-73. PubMed ID: 17962026
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction with sigma(1) protein, but not N-methyl-D-aspartate receptor, is involved in the pharmacological activity of donepezil.
    Maurice T; Meunier J; Feng B; Ieni J; Monaghan DT
    J Pharmacol Exp Ther; 2006 May; 317(2):606-14. PubMed ID: 16397090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of novel LP1-based analogues with enhanced delta opioid receptor profile.
    Pasquinucci L; Turnaturi R; Prezzavento O; Arena E; Aricò G; Georgoussi Z; Parenti R; Cantarella G; Parenti C
    Bioorg Med Chem; 2017 Sep; 25(17):4745-4752. PubMed ID: 28734666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological studies with a nonpeptidic, delta-opioid (-)-(1R,5R,9R)-5,9-dimethyl-2'-hydroxy-2-(6-hydroxyhexyl)-6,7-benzomorphan hydrochloride ((-)-NIH 11082).
    Aceto MD; May EL; Harris LS; Bowman ER; Cook CD
    Eur J Pharmacol; 2007 Jul; 566(1-3):88-93. PubMed ID: 17434480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo evidence for benzomorphan-selective receptors in rats.
    Gmerek DE; Cowan A
    J Pharmacol Exp Ther; 1984 Jul; 230(1):110-5. PubMed ID: 6146703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sigma-1 receptor activation prevents intracellular calcium dysregulation in cortical neurons during in vitro ischemia.
    Katnik C; Guerrero WR; Pennypacker KR; Herrera Y; Cuevas J
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1355-65. PubMed ID: 16988055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of 9-hydroxylation on benzomorphan antagonist activity.
    Albertson NF
    J Med Chem; 1975 Jun; 18(6):619-21. PubMed ID: 1151978
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Norbenzomorphan Framework as a Novel Scaffold for Generating Sigma 2 Receptor/PGRMC1 Subtype-Selective Ligands.
    Sahn JJ; Hodges TR; Chan JZ; Martin SF
    ChemMedChem; 2016 Mar; 11(6):556-61. PubMed ID: 26915462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 10-Hydroxy-4-methyl-2,3,4,5,6,7-hexahydro-1,6-methano-1H-4-benzazonine derivatives (homobenzomorphans) as analgesics.
    Shiotani S; Kometani T
    J Med Chem; 1976 Jun; 19(6):803-6. PubMed ID: 7674
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective sigma-1 receptor antagonists for the treatment of pain.
    Almansa C; Vela JM
    Future Med Chem; 2014 Jun; 6(10):1179-99. PubMed ID: 25078137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.